Cara Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CARA and buy or sell other stocks, ETFs, and their options commission-free!

About CARA

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. 

CEO
Christopher A. Posner
CEOChristopher A. Posner
Employees
55
Employees55
Headquarters
Stamford, Connecticut
HeadquartersStamford, Connecticut
Founded
2004
Founded2004
Employees
55
Employees55

CARA Key Statistics

Market cap
875.49M
Market cap875.49M
Price-Earnings ratio
-2.44
Price-Earnings ratio-2.44
Dividend yield
—
Dividend yield—
Average volume
6.55M
Average volume6.55M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.15
52 Week high$1.15
52 Week low
$0.2257
52 Week low$0.2257
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.